贝塔投资智库·2025-07-23 04:15Core Viewpoint - Morgan Stanley's strategy team highlights 15 stocks with short-term catalytic potential, indicating that S&P 500 index earnings growth in Q2 may exceed expectations [1] Earnings Expectations - The market anticipates a 5% year-over-year increase in S&P 500 Q2 earnings per share and over 4% revenue growth, but actual growth may be stronger [1] - The seven major tech companies are expected to see a 14% increase in net profit, while the remaining 493 constituents may experience a 3% decline [1] - Despite analysts lowering earnings expectations from April to May, the earnings revision has rebounded from -25% to approximately 1%, suggesting Q2 earnings will likely exceed expectations, aligning with the historical average of 4%-5% [1] Recommended Stocks - argenx SE (ARGX.US): undervalued R&D pipeline, target price $700 [2] - Atlassian (TEAM.US): continuous revenue growth potential over 20% and expected margin expansion, target price $320 [3] - Chewy (CHWY.US): benefits from marketing and product optimization, expected revenue to maintain or exceed Q1 levels, target price $50 [4] - CVS Health (CVS.US): advantages from competitor store closures and growth in pharmacy benefit management, target price $80 [4] - DraftKings (DKNG.US): potential earnings inflection point in Q2, with actual licensing rates offsetting tax and regulatory pressures, target price $52 [4] - Eaton Corporation (ETN.US): benefits from improved profit margins in U.S. electrical business, target price $375 [5] - Eli Lilly (LLY.US): core products Mounjaro and Zepbound expected to contribute $8.2 billion in revenue, exceeding expectations may lead to 2025 guidance upgrades, target price $1,135 [5] - F5 (FFIV.US): positive outlook due to demand growth in cloud and load balancing products, target price $305 [6] - NVIDIA (NVDA.US): strong end-user demand and accelerated shipments of rack-level products supporting supply-side growth, target price $170 [7] - Omada Health (OMDA.US): operational leverage through technology empowerment and multi-disease sales, target price $25 [8] - Southwest Airlines (LUV.US): potential stock rebound if internal guidance is met and baggage fee impacts are confirmed as limited, target price $38 [9] - Valley National Bank (VLY.US): expected net interest income growth of 3% quarter-over-quarter, target price $11 [10] - Western Digital (WDC.US): undervalued gross margin expansion prospects, target price $85 [11] Cautious Outlook - National Storage Affiliates Trust (NSA.US): cautious due to expected funds from operations (FFO) per share being below market and company guidance, target price $30 [12] - Teradyne (TER.US): revenue and earnings per share forecasts for FY2026 are 7% and 14% below Wall Street expectations, target price $74 [13] Summary - Overall, Morgan Stanley's recommendations combine company fundamentals, industry trends, and market sentiment, providing diversified options for investors [14]